EMEA-003316-PIP01-22
Submitted by Anonymous (not verified) on 13 September 2024 - 14:12
EMEA-003316-PIP01-22
Human medicines European public assessment report (EPAR): Adenuric, febuxostat, Date of authorisation: 21/04/2008, Revision: 23, Status: Authorised
Submitted by Anonymous (not verified) on 13 September 2024 - 13:55
Human medicines European public assessment report (EPAR): Adenuric, febuxostat, Date of authorisation: 21/04/2008, Revision: 23, Status: Authorised
EMEA-003346-PIP01-22
Submitted by Anonymous (not verified) on 13 September 2024 - 13:42
EMEA-003346-PIP01-22
EMEA-003348-PIP01-22
Submitted by Anonymous (not verified) on 13 September 2024 - 13:35
EMEA-003348-PIP01-22
EMEA-003415-PIP01-23
Submitted by Anonymous (not verified) on 13 September 2024 - 13:30
EMEA-003415-PIP01-23
EMEA-003418-PIP01-23
Submitted by Anonymous (not verified) on 13 September 2024 - 13:27
EMEA-003418-PIP01-23
EMEA-003423-PIP01-23
Submitted by Anonymous (not verified) on 13 September 2024 - 13:15
EMEA-003423-PIP01-23
EMEA-003427-PIP01-23
Submitted by Anonymous (not verified) on 13 September 2024 - 13:10
EMEA-003427-PIP01-23
EMEA-003427-PIP02-23
Submitted by Anonymous (not verified) on 13 September 2024 - 13:07
EMEA-003427-PIP02-23
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 10-12 September 2024
Submitted by Anonymous (not verified) on 13 September 2024 - 12:50
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 10-12 September 2024